课题基金 / 基金详情

Development of Recombinant Vaccinia Virus Vaccine Against Adult T-cell Leukemia

Development of Recombinant Vaccinia Virus Vaccine Against Adult T-cell Leukemia
成人T细胞白血病重组痘苗病毒疫苗的研制
批准号:
62870021
负责人:
SHIDA Hisatoshi
金额:
$12.16万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research
财政年份:
1987
资助国家:
日本
项目状态:
已结题
起止时间:
1987 至 1988

项目摘要

项目成果

SHIDA Hisatoshi的其他基金

相似基金

相关文献

中文摘要
翻译
1)为构建高水平表达外源基因的牛痘病毒载体,克隆了牛痘病毒a型包涵体(ATI)的编码基因。ATI基因的启动子比p7.5基因的启动子强数倍。为了构造更好的启动子,我们将ATI启动子与p7.5启动子的几组早期区域结合,得到了在vv感染的早期和晚期都能发挥良好作用的启动子。2)检测了表达env、gag和px基因的重组VV_s的性质。它们都产生了真正的htlc - 1蛋白。3)用表达env基因的重组VV免疫家兔,对htlv - 1产生细胞(MT-2)的攻击具有保护作用。在对野食蟹进行类似实验时,发现除了抗嫉妒抗体外,T细胞的启动也起着重要的保护作用。4) LC16mO在不同VV毒株中诱导的抗enb抗体水平很高,但其神经毒力很低。因此,该菌株是人类疫苗接种载体的良好候选者。5)为了检测JTLV-I的哪个成分是细胞毒性T细胞(CTL)的靶点,我们将产生HTLV-I成分的大鼠细胞感染到同基因大鼠体内,然后用各种重组vv感染的大鼠细胞检测其淋巴样细胞的CTL活性。结果表明,gag蛋白和pX蛋白是主要的靶点。
英文摘要
1) To develop the vaccinia virus vectors(VV) that express foreign genes at higher level, we cloned the gene encoding A-type inclusion body (ATI) of cowpox virus. The promoter of ATI gene was seceral times stronger than that of p7.5 gene. To constract better promoter, we combined the ATI promoter and the several sets of early region of p7.5 promoter so as to obtain the promoter which can act very well at both early and late times of vv infection.2) We examined the properties of the recombinant VV_s that express the env, gag or px gene.They all produced authentic HTLC-I proteins.3) The rabbits which had been immunized by the recombinant VV expressing the env gene were protected from challenge of the HTLV-I producing cells (MT-2). When the similar experiment using cynomolgus nomkeys was done, it was rebealed that not only anti env antibodies but also priming of T cells were important for the protection.4) LC16mO among various VV strains induced anti enb antibody at quite high level although it had very low neurovirulence. Thus, this strain is a good candidate as a vector for vaccination of humans.5) To examine which component of JTLV-I is the target of cytotoxic T cells (CTL), rat cells producing HTLV-I components were inhected into the syngenic rats and then the CTL activity of their lymphoid cells were measured using the various recombinant VV-infected rat cells. The results showed that gag and pX proteins were the major targets.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
志田壽利: 臨床とウィルス.
Hisatoshi Shida:临床实践和病毒。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
志田壽利: 臨床とウイルス.
Hisatoshi Shida:临床实践和病毒。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Specific recovery of exhausted T cells against HTLV-1
    • 批准号:
      23650606
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      SHIDA Hisatoshi
    • 依托单位:
    Elicitation of broad neutralizing antibodies to HIV-1 and development of infection rat model
    • 批准号:
      21390135
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2009
    • 负责人:
      SHIDA Hisatoshi
    • 依托单位:
    Construction of a transgenic rat model, which is highly sensitive to HTLV-1 infection
    • 批准号:
      14370098
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.58万
    • 财政年份:
      2002
    • 负责人:
      SHIDA Hisatoshi
    • 依托单位:
    Cellular cofactors involved in transport of mRNAs of complex retroviruses and hepatitis B virus
    • 批准号:
      11470079
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $3.07万
    • 财政年份:
      1999
    • 负责人:
      SHIDA Hisatoshi
    • 依托单位:
    海外基金